Neuroscientist and Business Executive with 15+ years of Medtech experience managing complex environments from acquisitions to consolidated businesses with P&Ls up to $140M all with high single to double digit growth % YOY. Head of Medtronic Deep Brain Stimulation for 10 years both as the European sales director and Global commercialization lead. Lover of value-based healthcare innovation leading to healthcare sustainability.

Founder and Chief Scientific Officer of InBrain Neuroelectronics. He is ICREA Professor at the Catalan Institute of Nanoscience and Nanotechnology (ICN2). He is a pioneer in the use of 2D materials, such as graphene for application in biosensing, bioelectronics and neural interfaces. He coordinates several European and National initiatives to develop graphene-based neural implants for bi-directional communication with the nervous system.

Bert is an experienced executive with over 30 years of experience in Research and Development. He has been leading cross-functional teams in the development of high-risk (Class III) medical devices. He worked for Philips Research, Sapiens Steering Brain Stimulation, Medtronic and GTXmedical. Recognized expert in electronics, with vast experience in requirements management. Bert holds a TU/e master degree in Electrical Engineering.

Professor of Marketing at IESE Business School. He serves as Executive Board Member of the digital marketing agency InboundCycle (Spain) and of the artificial intelligence software company Skim AI (NY, USA) and was formerly a consultant for McKinsey & Company. He holds a Ph.D. in Business Administration from UC Berkeley and a MSc in Mechanical & Aerospace Engineering from Arizona State University.

Physics engineer with a PhD in physics. He worked 15 years at Philips Research as a Principal Scientist, before spinning out and co-founding Sapiens Steering Stimulation in 2011, bringing the first thin-film-based, directional DBS lead ever to acute, human study in 2013. After that, he became a Director for Research and Technology at the Medtronic Eindhoven Design Center. Self-employed consultant since 2018, advising medtech startups.

Chair of Nanomedicine at the Faculty of Biology, Medicine & Health and the National Graphene Institute at the University of Manchester and is the Severo Ochoa Distinguished Professor at the ICN2. He obtained his Diploma in Chemical Engineering and PhD from the Department of Chemical Engineering at Imperial College London. He has been included in the Highly Cited Researcher 2018 list in the Cross-Field category.

Anton Guimerà-Brunet is staff researcher of IMB-CNM (CSIC) specialized in the development of micro-nanosystems for biomedical applications with a strong background in the development of medical devices and system integration for novel technologies. His research interests are the study of the electrical properties of biological tissues and the design of advanced neural interfaces.

Marcos has spent over 20 years in Healthcare, Entrepreneurship and Management Consulting industries. As former Medtronic Europe & Canada RTG group finance director he led several innovative projects and transactions, including some Neuromodulation (DBS) related. Later in his career he developed a successful track-record as early and late-stage investor in technology companies. He has raised funds and advised startups across the globe.